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Abstract
Fuzi (lateral root of Aconitum carmichaelii) has been used for millennia in Traditional Chinese Medicine (TCM) and Ayurveda to treat 
cancer and cardiovascular diseases. Fuzi must be processed before use to decrease the concentration of its toxic alkaloids. 
Detoxification during processing occurs through the transformation of diester-diterpenoid alkaloids (DDAs) to monoester-diter-
penoid alkaloids (MDAs). However, traditional detoxification methods are time-consuming and expensive on large-scale produc-
tion. To develop efficient detoxification protocols to reduce unnecessary processing procedure and keep the maximum functional 
contents from raw Fuzi, we replicated the traditional procedure and quantified the DDAs and MDAs by UPLC-MS/MS and 
UPLC-PDA during different steps and conditions of processing. With due consideration of obtained data, we concluded that 
soaking in Danba solution and the washing steps were inefficient traditional processing methods. The detoxification effect of 
steaming (56.3 ± 0.27 μg/g DDAs, lowest after steaming) was weaker and slower than boiling (5.8 ± 0.33 μg/g DDAs, lowest after 
boiling). Moreover, roasting at 105℃ showed better effect in lowering the DDAs (5.8 ± 0.33 μg/g DDAs) and increasing the 
MDAs (729.1 ± 1.22 μg/g MDAs, highest) than roasting at 60℃ (17.3 ± 0.65 μg/g DDAs; 504.0 ± 0.99 μg/g MDAs). With these 
highly reliable analytic data, we established an efficient and ref-
erenceable detoxification protocol for Fuzi TCM products, in 
which DDAs and MDAs should legitimately follow the safe 
and specific ranges stipulated in pharmacopeias.
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Fuzi, the lateral root of  Aconitum carmichaelii Debeaux, has been 
widely used in Chinese medicine for tumors, poor circulation, 
heart failure, and pain.1 It was first introduced 2000 years ago in 
Shennong Bencao Jing, the earliest book of  Chinese Materia 
Medica.2 Since then, Fuzi was used in many Traditional Chinese 
Medicine (TCM), Ayurvedic, Kampo, homeopathy, and herbal 
formulas to treat several clinical conditions such as heart failure, 
poor circulation, and different tumors.3 However, the toxicity of  
raw Fuzi has always been the main concern for healers and 
patients. There were more than 1000 published cases of  Aconitum 
poisoning worldwide.4,5 The common clinical presentation of  
Aconitum poisoning included cardiac arrhythmias, paresthesia and 
numbness over the face and limbs, nausea, dizziness, cold sweat-
ing, chest tightness, and hypotension.3 Although most patients 
could recover without a specific sequela after appropriate 
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treatment of  Aconitum poisoning, the usage of  Aconitum sp. 
should be under clinical supervision and strict regulation.
Since ancient times, TCM doctors developed detoxification 
processes such as soaking in water, stir-frying, boiling, roasting, 
and steaming to reduce the toxicity of  Fuzi.6 Some practi-
tioners mix Fuzi with the roots of  Glycyrrhiza uralensis Fisch., 
Panax ginseng C.A. Mey., or Zingiber officinale Roscoe to decrease 
toxicity and enhance efficacy of  Fuzi.2 According to recent 
studies, detoxification during processing or metabolism occurs 
through the hydrolysis of  the C-8 acetylester group of  
diester-diterpenoid alkaloids (DDAs) to form monoester-diter-
penoid alkaloids (MDAs).7 These monoesters are further 
debenzoylated at the C-14 to form hydramine-type unesterified 
diterpenoid alkaloids.6 According to the Taiwan Herbal 
Pharmacopeia (Figure  1), the total concentration of  DDAs 
(aconitine, mesaconitine, and hypaconitine) should not be 
above 0.02% (200 μg/g), as well as the total amount of  MDAs 
(benzoylaconine (BA), benzoylmesaconine (BM), and benzoyl-
hypaconine (BH)) should be over 0.01% (100 μg/g) in the 
commercial products of  Fuzi.8
In Taiwan, Fuzi commercial products should be processed 
following Taiwan Herbal Pharmacopeia or government-ap-
proved traditional protocols. According to traditional process-
ing protocol, the raw Fuzi is soaked in Danba salts (CaCl2, 
MgCl2, or NaCl) solution for antiseptic purposes and then 
washed (Figure  2). The soaking and washing process may 
reduce the active constituents such as DDAs and MDAs in 
Fuzi. However, the quantification change of  effective com-
pounds during the process was not clearly understood.9 
Moreover, the comparison of  detoxification processes such as 
boiling, steaming, and roasting was not established. Therefore, 
the current study aimed to establish the quantification data of  
Figure 1. The chemical structures of the six representative components in Fuzi: aconitine, mesaconitine, hypaconitine, benzoylaconine (BA), 
benzoylmesaconine (BM), and benzoylhypaconine (BH).
Figure 2. Standard processing procedures of Fuzi in traditional Chinese method.
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DDAs and MDAs during the traditional standard procedures, 
which may provide scientific evidences to TCM factories to 
develop efficient modern processing procedures.
Before processing, hypaconitine concentration (264.85 
µg/g) in raw Fuzi was the highest among the 3 DDAs, followed 
by mesaconitine (107.59 µg/g) and aconitine (73.37 µg/g). The 
mean of  sum of  DDAs concentration was 445.8 ± 3.52 µg/g. 
Among MDAs, BM concentration (78.64 µg/g) was the highest 
followed by BA (33.47 µg/g) and BH (21.53 µg/g). The mean 
of  sum of  MDAs concentration was 133.6 ± 0.57 µg/g in the 
raw Fuzi sample.
Soaking in Danba salt was the first step of  processing raw 
Fuzi according to traditional Chinese methods (Figure 2). The 
duration of  traditional soaking process was between 10 and 16 
days. We evaluated the concentration change of  DDAs and 
MDAs of  1000 g raw Fuzi slices, which were soaked in satu-
rated Danba salt solution for 10 or 16 days. After that, Fuzi 
slices were boiled with Danba salt solution for 30 minutes. 
Sliced Fuzi samples were then dried at 70°C and prepared for 
analysis.10
The sum of  DDAs was 107.8 ± 5.65 µg/g in the 16-day 
soaking group and 16.8 ± 0.08 µg/g in the 10-day group. After 
soaking and boiling, aconitine concentration was reduced to 
18.13 µg/g in the 16-day group and to 2.45 µg/g in the 10-day 
group. Hypaconitine concentration was reduced to 37.42 µg/g 
in the 16-day and 6.49 µg/g in the 10-day group. Mesaconitine 
concentration was also reduced to 52.21 and 6.49 µg/g, respec-
tively. As for MDAs, the 16-day soaking group had also higher 
concentration of  MDAs (29.9 ± 0.04 µg/g) than the 10-day 
soaking group (8.9 ± 0.02 µg/g). BA concentration was reduced 
to 4.02 µg/g in the 16-day group, and barely undetectable in 
the 10-day group. BH concentration was similar (3.34 µg/g vs 
3.95 µg/g) in the 16-day and the 10-day group, respectively. BM 
concentration was significantly higher in the 16-day soaking 
group (22.52 µg/g) compared to the 10-day group (4.91 µg/g). 
Although soaking in Danba solution decreased the concentra-
tions of  DDAs and MDAs, these samples did not meet com-
mercial products qualifications due to low MDAs concentration 
(8.9-16.8 μg/g) just after soaking and boiling steps. Surprisingly, 
DDAs and MDAs increase after soaking for a longer time. 
However, the mechanism was unclear. In our speculation, 
Danba salt was not washed out clearly in the first 2 steps, which 
might interfere with the release of  DDAs and MDAs in Fuzi 
slices for analysis.11 Therefore, we recommended to add some 
time points, such as 5-day, 8-day, and 13-day groups, to obtain 
the change trend of  alkaloids concentration in the future study.
After soaking, Danba salt was washed out clearly because of  
its possible toxicity (Figure 2).3 Traditionally, Fuzi slices were 
picked up from saturated Danba solution and then put into 
water to wash out Danba salt. The water was changed regularly 
within the washing procedures, which persisted for about 3 to 
4 days.12 After washing out Danba salt, Fuzi was steamed and 
prepared to undergo further processing procedure. Therefore, 
the second experiment aimed to illustrate the effect of  washing 
and steaming on the change of  concentration of  diterpenoid 
alkaloids. Raw Fuzi slices were soaked in saturated Danba salt 
solution for 10 days and boiled for 30 minutes. Samples under-
went washing procedures for 3 days and were steamed for 1, 2, 
or 3 hours. Samples were then dried at 70°C and prepared for 
analysis.
The current study proved that washing and steaming were 
effective steps for detoxification. The concentration of  total 
DDAs was not significantly different after 10-day soaking and 
boiling (16.8 ± 0.08 µg/g) compared to 12.5 to 27.5 μg/g after 
washing and steaming (Table 1). We noticed that the concen-
tration of  hypaconitine increased by the steaming duration. We 
supposed that other alkaloids could be turned into hypaconi-
tine by steaming procedure. In contrast, the concentration of  
total MDAs significantly increased from 8.9 to 50.0 to 125.8 
μg/g in different steaming time. The samples after steaming 
for 3 hours were qualified as commercial products, because the 
total amount of  MDAs was above 0.01% (100 μg/g). Moreover, 
the results indicated that MDAs might not have only originated 
from the hydrolysis of  DDAs. Therefore, the transformation 
of  diterpenoid alkaloids is worth further studies.
In China and Japan, there are some commercial Fuzi prod-
ucts sold on the market by Chinese companies, in which Danba 
salt is not used during processing and no washing is applied. 
Some of  the products were processed by boiling and roasting, 
and the others were processed by steaming and roasting. 
Table 1. The Change of Diterpenoid Alkaloids Concentration After Washing and Steaming Procedure.
Steaming
time
Diester-diterpenoid alkaloids
Aconitine
(μg/g)
Hypaconitine
(μg/g)
Mesaconitine
(μg/g)
Mean of  sum
(μg/g)
1 h 1.26 8.71 2.57 12.5 ± 0.02
2 h 1.64 9.65 3.02 14.3 ± 0.22
3 h 1.31 22.88 3.29 27.5 ± 1.47
  Steaming
  time
Monoester-diterpenoid alkaloids
Benzoylaconine (μg/g) Benzoylhypaconine (μg/g) Benzoylmesaconine (μg/g) Mean of  sum
(μg/g)
1 h 7.51 6.83 35.69 50.0 ± 0.07
2 h 14.21 10.33 62.17 86.7 ± 0.07
3 h 20.42 23.81 81.58 125.8 ± 0.07
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However, we did not know whether DDAs of  these products 
were above the upper limitation of  the regulation in Taiwan. 
Raw Fuzi samples were divided into 2 groups. One group was 
processed by boiling and the other by steaming for 1, 2, and 6 
hours. All samples were then roasted at 60℃ or at 105℃ for 8 
hours.10
The boiling process was more effective to decrease the 
amount of  DDAs than the steaming process. Roasting at 
105℃ could further decrease the concentrations of  DDAs 
compared to roasting at 60℃ (Tables 2 and 3).
In contrast, the boiling and steaming processes were both 
effective to increase the number of  MDAs. Steaming for 6 
hours and roasting at 105℃ for 2 hours had the highest con-
centration of  MDAs (729.1 µg/g) among all groups (Tables 2 
and 3). The amount of  increased MDAs was more than the 
decreased DDAs, so it proved that BA, BH, and BM could not 
have originated only from aconitine, hypaconitine, and mesac-
onitine. To the best of  our knowledge, the current study was 
the first to demonstrate that raw Fuzi could be qualified even 
without the Danba soaking and washing process.
In order to decrease the cost and improve production, 
herbal Good Manufacturing Practice (GMP) factories need to 
find an efficient way to detoxify Fuzi and maintain the concen-
tration of  its active components. Under formal regulations, the 
detoxification process should follow the procedures described 
in ancient texts, which might not be the most effective way. 
Although ultrasonic bath and microwave-assisted extraction 
were applied on small scale to shorten the extraction time,13,14 
these procedures are not economically feasible for mass 
production.
The current study showed that soaking in Danba solution 
and washing process were unnecessary to produce qualified 
commercial products. Moreover, boiling or steaming more 
than 2 hours could decrease the total concentration of  DDAs 
to less than 0.02% (200 μg/g). Roasting at 105℃ could save 
time compared to roasting at 60℃. The factories could develop 
and improve their processing procedures based on the current 
study.
“Processing” is an important technique in Chinese 
Herbology. The purpose of  it is to alter the properties of  crude 
medicinal materials, so as to enhance the active ingredients 
responsible for pharmacodynamic effects. Oppositely, it also 
plays a very crucial role in reducing or decomposing poison 
components to prevent any possible abnormal, adverse, or 
harmful risks in clinical administration. Different ways of  heat-
ing, even combined with accompanying materials, are the most 
common and traditional approaches conducted for prepara-
tion. Both DDAs and MDAs are active compounds of  Fuzi. 
However, the therapeutic windows of  DDAs, eg aconitine, are 
extremely narrow with an estimated lethal dose around 2 to 
6  mg for humans.15 Its poisoning symptoms were well known 
as hypotension, palpitation, ventricular tachyarrhythmia, asys-
tole, and numbness of  the face and limbs.16 In contrast, the 
toxicity of  the MDAs was about 1000-fold weaker, with the 
LD50 values (oral, mice) of  benzoylaconine, 
benzoylmesaconine, and benzoylhypaconine as 1.50, 0.81, and 
0.83 g/kg, respectively.17
In this work, we were aiming to quantify and monitor the 
trajectory of  diterpenoid alkaloid changes during processing 
of  Fuzi. Washing, boiling, steaming, and roasting now can be 
commonly controlled/standardized by professional equipment 
in TCM pharmaceutical companies issued with GMP certifi-
cate. With the highly reliable analytic data collected by validated 
UPLC-MS/MS and UPLC-PDA, we established an efficient 
and referenceable protocol for the manufacture of  commercial 
Fuzi TCM products, in which DDAs and MDAs should legiti-
mately follow the safe and specific ranges.
In conclusion, we suggested that the competent authority 
of  Chinese Medicine Manufacturing should not simply follow 
the traditional processing method, and there might be effective 
scientific methods to improve the quality of  processing of  all 
kinds of  Chinese herbs.
Experimental
Plant Material
Raw Fuzi is the daughter root of  Aconitum carmichaelii Debeaux, 
which was cultivated and brought from Jiangyou, Sichuan, 
China. The raw plant material was identified by Dr Shu-Tuan 
Chiang. A voucher specimen (code no. Aconitum 001) was 
stored in the Graduate Institute of  Natural Products, College 
of  Pharmacy, Kaohsiung Medical University and Chuang Song 
Zong Pharmaceutical Co. Ltd., Taiwan. Raw Fuzi was cut into 
slices and dried. Danba salt was purchased from Sichuan 
Xinhehua Company (Sichuan, China).
Chemicals and Reagents
Chemical standards of  aconitine, mesaconitine, hypaconitine, 
benzoylaconine, benzoylhypaconine, and benzoylmesaconine 
were purchased from Kishida Chemical Co., Ltd (Osaka, 
Japan). LC/MS and HPLC grade methanol (J.T. Baker, 
Phillipsburg, USA), LC/MS grade acetonitrile (J.T. Baker), LC/
MS grade 0.1% formic acid/acetonitrile (J.T. Baker), ACS grade 
diethyl ether (Echo, Leiden, Netherlands), HPLC grade acetic 
acid (Echo), ACS grade ammonium hydroxide solution (28%-
30%; Tedia, Fairfield, USA), ACS grade 0.1% formic acid 
(Sigma-Aldrich, St Louis, USA), GR grade isopropanol (Tedia), 
ACS grade ethyl acetate (Echo), GR grade dichloromethane, 
ortho-phosphoric acid (85%, Merck, Darmstadt, Germany), and 
deionized water (resistivity ≧ 16 million ohm-cm) were used 
for the preparation of  standard solutions, sample solutions, 
and mobile phases for UPLC.
Sample Preparations
The preparation of  extract for investigation of  DDA analysis 
was as follows18: Accurately weigh 1.0 g sample and put it into 
a 50 mL centrifuge tube. Add 1 mL 10% ammonium hydroxide 
solution. Stir well to ensure that the entire sample is wet. Then 
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add 25 mL diethyl ether to the tube. Shake the tube on a plat-
form shaker for 1 hour at a speed of  300 rpm. Centrifuge the 
sample at 4000 rpm for 10 minutes to settle the solids. Decant 
the diethyl ether into another centrifuge tube. Repeat the sam-
ple extraction twice each time with 10 mL diethyl ether, and 
shake the tube for 30 and 10 minutes, respectively. Combine 
the extracts and evaporate to complete dryness at ≤40°C under 
a stream of  nitrogen. Add 5 mL acetonitrile-0.1% acetic acid (1 
+ 1) and ultrasonicate for 20 minutes to re-dissolve the resi-
dues. The solution is ready for SPE cleanup after it is passed 
through a 0.45 µm membrane filter.
The preparation of  extract for investigation of  MDA anal-
ysis was as follows8: Samples were shredded by shredding 
machine for 20 minutes to make sample powders. Weigh accu-
rately 2.0 g of  powdered sample, transfer to a conical flask with 
stopper, add 3 mL of  ammonia solution, accurately add 50 mL 
of  a solution of  isopropanol and ethyl acetate (1:1), weigh, 
ultrasonicate for 30 minutes, cool, weigh again, replenish the 
loss of  the weight with a solution of  isopropanol and ethyl 
acetate (1:1), mix well, filter, transfer 25 mL of  successive fil-
trate, evaporate the filtrate to dryness on 40℃, dissolve the 
residue in a solution of  isopropanol and dichloromethane (1:1) 
to 3 mL, filter, and use the filtrate.
Instrumentation, UPLC-MS/MS, and UPLC-PDA 
Analysis
An ACQUITY UPLC system (Waters, Milford, MA, USA) 
consisting of  binary or quaternary solvent manager, sample 
manager, column manager, ACQUITY TQ detector, and PDA 
detector was used for acquiring chromatograms, UV spectra, 
and plots of  retention time-absorbance-wavelength. All the 
instruments used for analyses were regularly and well validated 
by the quality control department of  Chuang Song Zong 
Pharmaceutical Co. Ltd. A DC600H ultrasonic processor 
(Delta, Taipei, Taiwan) was used for sample extraction and a 
Universal 32 (Hettich, Tuttlingen, Germany) centrifuge for 
sample preparation.
The standard solutions of  aconitine, hypaconitine, and 
mesaconitine were prepared through procedures for analysis.18 
UPLC operating conditions were as follows: injection volume: 
2 µL; TQ detector was set to selected reaction monitoring 
mode with positive electrospray ionization. The analytical col-
umn for DDA analysis was an ACQUITY UPLC BEH C18 
column (1.7 µm, 50 mm × 2.1 mm) (Waters). The mobile phase 
consisted of  water and 0.1% formic acid (A) and acetonitrile 
and 0.1% formic acid (B). The flow rate was 0.5 mL/min. 
Separation was performed at 35°C by means of  a gradient elu-
tion program. Elution started with 90% A. The concentration 
of  phase A decreased linearly to 20% within 30 minutes. 
Aconitine, mesaconitine, and hypaconitine precursor ions ([M 
+ H]+) and their corresponding fragments were monitored 
(m/z 646→586, m/z 632→572, and m/z 616→556)18 
(Figure 3).
The standard solutions of  benzoylaconine, benzoyl-
hypaconine, and benzoylmesaconine were prepared through 
procedures for analysis.8 The analytical column for MDAs was 
an ACQUITY UPLC HSS C18 column (1.8 µm, 100 mm × 2.1 
mm) (Waters). UV detection was carried out at 235 nm. The 
mobile phase consisted of  water and 0.2% phosphoric acid (A) 
and 0.2% phosphoric acid in methanol (B). Column separation 
was performed at 30°C by means of  a gradient elution with a 
flow rate of  0.3 mL/min. Elution started with 75% A and the 
ratio of  A decreased linearly to 50% within 30 minutes 
(Figure 4).
Figure 3. UPLC-ESI-MS/MS chromatogram of aconitine, 
hypaconitine, and mesaconitine from Fuzi.
Figure 4. UPLC-PDA chromatogram of benzoylaconine (BA), 
benzylhypaconine (BH), and benzoylmesaconine (BM) from Fuzi.
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Data Analysis
Data are reported as mean ± standard deviation values of  at 
least 3 independent experiments.
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